Package 0615-8582-39

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0615-8582-39
Digits Only 0615858239
Product NDC 0615-8582
Product ID 0615-8582_4f5269c7-b48c-4855-8a4b-6852522d3aea
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8582-39)

Marketing

Marketing Status
Marketed Since 2025-07-18
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4f5269c7-b48c-4855-8a4b-6852522d3aea", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["4fbe64aa-f8f4-45fa-88ae-e844997703ae"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8582-39)", "package_ndc": "0615-8582-39", "marketing_start_date": "20250718"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "0615-8582_4f5269c7-b48c-4855-8a4b-6852522d3aea", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0615-8582", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA075491", "marketing_category": "ANDA", "marketing_start_date": "20240425", "listing_expiration_date": "20261231"}